Spero Therapeutics (SPRO) executive compensation, 2026 proxy

Esther Rajavelu, President and Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer, was paid $2.1M in 2025, up 141% from $856,479 the year before.

Filed
April 27, 2026
Annual meeting
June 23, 2026
Pay year
2025
Named executives
3
CEO total pay
$2.1M+141% vs prior year
CEO pay in equity
20%$413,705 in awards
CEO 2025 Salary
$577,179
CEO 2025 Total Pay
$2,061,496
Former CEO 2025 Pay
$2,025,178

How Rajavelu was paid

$2.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary28%Bonus33%Stock awards20%Non-equity incentive18%All other compensation1%

Named executive officers

ExecutiveTotal
Esther RajaveluPresident and Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer$2,061,496
Tim KeutzerChief Operating Officer$1,440,820
Satyavrat ShuklaFormer President and Chief Executive Officer$2,025,178

What changed and why

  • $2.1MEsther Rajavelu received total compensation of $2,061,496 for fiscal 2025 following her appointment as President and CEO.
  • $577KEsther Rajavelu received a base salary of $577,179 and a retention bonus of $687,479 in 2025.
  • $1.4MTim Keutzer received total compensation of $1,440,820 for fiscal 2025 as Chief Operating Officer.
  • $2MSatyavrat Shukla stepped down as President and CEO on May 2, 2025, receiving total compensation of $2,025,178.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.